Skip to main content

Table 2 Implied coverage rates for a base-case scale-up scenario (%)

From: Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Country Categorya Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10
   2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
AFR D            
   Angola 10           31.0
   Benin 5      15.0 30.6 46.2 61.8 77.4 93.0
   Burkina Faso 5      57.0 65.4 73.8 82.2 90.6 99.0
   Cameroon 3    53.0 60.8 68.5 76.3 84.0 84.0 84.0 84.0
   Chad 8         28.0 30.5 33.0
   Comoros 7        27.0 36.0 45.0 54.0
   Ghana 6       80.0 81.4 82.8 84.2 85.6
   Guinea 8         57.0 59.2 61.3
   Guinea-Bissau 9          47.0 51.6
   Liberia 5      48.0 56.8 65.6 74.4 83.2 92.0
   Madagascar 6       61.0 66.4 71.8 77.2 82.6
   Mali 5      54.0 63.0 72.0 81.0 90.0 99.0
   Mauritania 8         31.0 38.2 45.3
   Niger 9          25.0 34.1
   Nigeria 4     41.0 44.2 47.4 50.6 53.8 57.0 57.0
   Sao Tome 3    43.0 57.0 71.0 85.0 99.0 99.0 99.0 99.0
   Senegal 6       54.0 60.8 67.6 74.4 81.2
   Sierra Leone 6       24.0 36.6 49.2 61.8 74.4
   The Gambia 5      84.0 86.4 88.8 91.2 93.6 96.0
   Togo 6       50.0 57.8 65.6 73.4 81.2
AFR E            
   Burundi 10           74.0
   Central African Republic 10           29.0
   Congo 10           33.0
   Cote d'Ivoire 4     10.0 22.8 35.6 48.4 61.2 74.0 74.0
   Democratic Republic of the Congo 10           40.0
   Eritrea 6       52.0 58.6 65.2 71.8 78.4
   Ethiopia 6       42.0 49.8 57.6 65.4 73.2
   Kenya 6       72.0 74.6 77.2 79.8 82.4
   Lesotho 3    14.0 33.3 52.5 71.8 91.0 91.0 91.0 91.0
   Malawi 5      64.0 69.4 74.8 80.2 85.6 91.0
   Mozambique 8         25.0 34.2 43.3
   Rwanda 5      88.0 89.8 91.6 93.4 95.2 97.0
   Tanzania 7        79.0 79.8 80.7 81.5
   Uganda 8         29.0 37.3 45.7
   Zambia 5      80.0 83.0 86.0 89.0 92.0 95.0
   Zimbabwe 8         9.0 20.0 31.0
AMR A, B & D            
   Cuba 1 93.0 95.0 97.0 99.0 99.0 99.0 99.0 99.0 99.0 99.0
   Guyana 1 89.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0
   Honduras 1 84.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0 93.0
   Bolivia 1 82.0 83.0 83.0 83.0 83.0 83.0 83.0 83.0 83.0 83.0
   Haiti 10           39.0
   Nicaragua 1b 96.0 96.0 96.0 96.0 96.0 96.0 96.0 96.0 96.0 96.0
EMR D            
   Afghanistan 10           31.0
   Djibouti 2   46.0 56.8 67.5 78.3 89.0 89.0 89.0 89.0 89.0
   Pakistan 4     63.0 65.0 67.0 69.0 71.0 73.0 73.0
   Somalia 9          33.0 32.7
   Sudan 3    22.0 39.8 57.5 75.3 93.0 93.0 93.0 93.0
   Yemen 6       9.0 24.6 40.2 55.8 71.4
EUR B & C            
   Armenia 1 55.0 66.3 77.7 89.0 89.0 89.0 89.0 89.0 89.0 89.0
   Azerbaijan 1 95.0 95.0 95.0 95.0 95.0 95.0 95.0 95.0 95.0 95.0
   Georgia 1 55.0 67.3 79.7 92.0 92.0 92.0 92.0 92.0 92.0 92.0
   Kyrgyzstan 1 10.0 38.3 66.7 95.0 95.0 95.0 95.0 95.0 95.0 95.0
   Tajikistan 1 39.0 54.7 70.3 86.0 86.0 86.0 86.0 86.0 86.0 86.0
   Uzbekistan 1 5.0 36.0 67.0 98.0 98.0 98.0 98.0 98.0 98.0 98.0
   Moldova 1 81.0 85.7 90.3 95.0 95.0 95.0 95.0 95. 0 95.0 95.0
   Ukraine 1 4.0 32.7 61.3 90.0 90.0 90.0 90.0 90.0 90.0 90.0
SEAR B & D            
   Indonesia 4     42.0 49.0 56.0 63.0 70.0 77.0 77.0
   Korea, Democratic Republic 10           27.0
   Sri Lanka 3    62.0 71.0 80.0 89.0 98.0 98.0 98.0 98.0
   Timor Leste 4     57.0 61.4 65.8 70.2 74.6 79.0 79.0
   Bangladesh 7        5.0 18.7 32.3 46.0
   Bhutan 3    90.0 91.5 93.0 94.5 96.0 96.0 96.0 96.0
   India 3    6.0 25.5 45.0 64.5 84.0 84.0 84.0 84.0
   Myanmar 7        8.0 20.8 33.7 46.5
   Nepal 7        2.0 15.3 28.7 42. 0
WPR B            
   Cambodia 5      50.0 58.2 66.4 74.6 82.8 91.0
   Kiribati 2   36.0 47.5 59.0 70.5 82.0 82.0 82.0 82.0 82.0
   Lao People Democratic Republic 8         50.0 51.8 53.7
   Mongolia 2   95.0 95.3 95.5 95.8 96.0 96.0 96.0 96.0 96.0
   Papua New Guinea 4     60.0 58.4 56.8 55.2 53.6 52.0 52.0
   Solomon Islands 2   53.0 59.3 65.5 71.8 78.0 78.0 78.0 78.0 78.0
   Viet Nam 5      78.0 81.0 84.0 87.0 90.0 93.0
  1. a The profile of each category is as follows:
  2. Category 1: 13 countries classified by Atherly et al.'s demand forecasting study [36] as "Phase 1" countries that are likely to introduce rotavirus vaccines earlier than other countries.
  3. Category 2: Lower middle per capita income ($976-3,705) and introduction of both Hib and HepB vaccines.
  4. Category 3: Lower middle per capita income ($976-3,705), either Hib or HepB vaccine introduction, and high (>80%) to very high (>90%) DTP3 coverage.
  5. Category 4: Lower middle per capita income ($976-3,705), either Hib or HepB vaccine introduction, and low (<70%) to moderate (>70%) DTP3 coverage.
  6. Category 5: Low income (<$975), Hib or HepB vaccine introduction, and very high (>90%) DTP3 coverage.
  7. Category 6: Low income (<$975), both Hib and HepB vaccine introduction, and high (>80%) DTP3 coverage.
  8. Category 7: Low income (<$975), either Hib or HepB vaccine introduction, and high (>80%) DTP3 coverage.
  9. Category 8: Low income (<$975), either Hib or HepB vaccine introduction, and low (<70%) to moderate (>70%) DTP3 coverage.
  10. Category 9: Low income (<$975), neither Hib nor HepB vaccine introduction.
  11. Category 10: 8 countries judged by Atherly et al. [36] to be countries that are not likely to introduce rotavirus vaccines.
  12. b Introduced rotavirus vaccine in 2006.